Stay updated with breaking news from Abecma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has accepted Bristol Myers Squibb's application for Breyanzi as a second-line treatment for relapsed or refractory large B-cell lymphoma. The regulator has assigned it priority review with a decision deadline of June 24.
The FDA has slapped a clinical hold on Takeda and Denali Therapeutics' phase 1-ready Alzheimer's candidate. Daiichi Sankyo is shutting down its Plexxikon R&D facility. Legend Biotech talks manufacturing learnings from Bristol Myers Squibb's CAR-T rival.
Mumbai: Global independent research firm RECMA has ranked Starcom India, part of Publicis Groupe India number one in new business in its ‘New Business Balance Report for 2021’. The research firm evaluates media agencies worldwide. The agency has gained the top position in competitive pitch wins across Consumer Products (CPG), New-Age, and App Economy which includes clients in
This fall, MIT joined the Black Economic Council of Massachusetts (BECMA), a Boston-based statewide organization that works to advance the economic well-being of Black businesses, organizations, and people in the Commonwealth.
King Boston today announced a partnership with the Black Economic Council of Massachusetts and NBC10 Boston, NECN, NBC Sports Boston, and Telemundo Boston to...